VRTXVertex Pharmaceuticals Incorporated Stock Analysis

Exchange: NASDAQ | Sector: Healthcare | Industry: Biotechnology

Current Price: $438.71 (-0.14% today)

Market Cap: $111.43B

P/E (TTM): 28.20

Forward P/E (FY1): 22.70

EPS Growth: 15.2%

Analyst Upside: 25.7%

Relative Strength (RS%): 26

-14.1% from 52-week high

Back to Scanner

VRTX

NASDAQRS 26Score 44

Vertex Pharmaceuticals Incorporated

HealthcareBiotechnology$111.43B3 setups passing
$438.71
-0.1% ($0.61)
-14.1% from 52W High
P/E (TTM)
28.20
Fwd P/E
22.70
PEG
0.87
Analyst Upside
+25.7%
EPS Growth
15.2%
Gross Margin
86.3%
ROE
22.7%
D/E
0.21
Div Yield
0.0%
Avg Volume
1.2M

Price Chart

Key Levels

SMA 200
$438.32
SMA 50
$467.89
Price
$438.71
52W High
$510.72
Target
$551.44

Setup Radar

3/8 passing
📈
CAN SLIMO'Neil
Near highs + RS ≥ 80
🎯
VCPMinervini
Within 25% high, RS ≥ 70, > 200 SMA
📊
Trend TemplateMinervini
> 50 & 200 SMA, RS ≥ 70, near high
🚀
Stage 2Weinstein
RS ≥ 60, > 200 SMA
📦
Darvas BoxDarvas
Near highs, > 200 SMA
Earnings MomentumGrowth
EPS growth ≥ 20%
🔍
PEG HunterLynch
PEG < 1.5, EPS growth ≥ 15%
🎪
Analyst UpsideConsensus
Target upside ≥ 15%, 1+ analyst